FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4324378500> ?p ?o ?g. }

• W4324378500 abstract "Approximately one-fifth of high-school seniors and college students currently vape nicotine. Adolescents express a desire to quit vaping, and case reports have shown promise for e-cigarette tapering with dual behavioral and pharmacologic therapies. However, there are no published clinical trials to date that test these intervention approaches for adolescent nicotine vaping cessation. In this three-arm randomized, placebo-controlled, parallel-group study, we aim to assess the efficacy of varenicline in combination with brief behavioral counseling and texting support on vaping cessation in adolescents dependent on vaped nicotine.The study will enroll 300 individuals between the ages of 16-25 with daily or near-daily nicotine vaping who reside in the Greater Boston area. Participants will be randomly assigned in a 1:1:1 ratio in blocks of six to one of the three arms: (1) a 12-week course of varenicline titrated to 1 mg bid, brief behavioral counseling delivered by a lay counselor, and an introduction to This is Quitting (TIQ) texting support created by the Truth Initiative; (2) a 12-week course of placebo, brief behavioral counseling, and TIQ; and (3) 12 weeks of enhanced usual care, consisting of advice to quit and an introduction to TIQ. The primary outcome will be biochemically verified continuous vaping abstinence at the end of the treatment (week 12). Secondary outcomes include continuous abstinence at follow-up (week 24), 7-day point prevalence abstinence at weeks 12 and 24, safety and tolerability of varenicline in an adolescent vaping population, as well as change in mood and nicotine withdrawal symptoms across the intervention period. Exploratory outcomes include change in comorbid substance use behaviors and nicotine dependence. Analysis will be intent-to-treat, with multiple imputation sensitivity analyses for participants with missing or incomplete outcome data.This is the first study to evaluate varenicline in combination with a novel, brief, lay counselor delivered vaping cessation program for adolescents who vape nicotine. Results will inform clinicians on the effectiveness and acceptability of this promising, but not yet tested intervention.Clinical trial registration: ClinicalTrials.gov, identifier NCT05367492." @default.
• W4324378500 created "2023-03-16" @default.
• W4324378500 creator A5007719765 @default.
• W4324378500 creator A5008815054 @default.
• W4324378500 creator A5011645136 @default.
• W4324378500 creator A5032101247 @default.
• W4324378500 creator A5039633744 @default.
• W4324378500 creator A5039651095 @default.
• W4324378500 creator A5059810022 @default.
• W4324378500 creator A5067852989 @default.
• W4324378500 creator A5072748186 @default.
• W4324378500 creator A5084985802 @default.
• W4324378500 date "2023-03-15" @default.
• W4324378500 modified "2023-09-30" @default.
• W4324378500 title "A randomized controlled trial of varenicline and brief behavioral counseling delivered by lay counselors for adolescent vaping cessation: Study protocol" @default.
• W4324378500 cites W1978136073 @default.
• W4324378500 cites W1989367790 @default.
• W4324378500 cites W2013762461 @default.
• W4324378500 cites W2030235211 @default.
• W4324378500 cites W2037401035 @default.
• W4324378500 cites W2045127388 @default.
• W4324378500 cites W2071488745 @default.
• W4324378500 cites W2087380582 @default.
• W4324378500 cites W2090667730 @default.
• W4324378500 cites W2095673783 @default.
• W4324378500 cites W2097005250 @default.
• W4324378500 cites W2130544434 @default.
• W4324378500 cites W2139205784 @default.
• W4324378500 cites W2142960568 @default.
• W4324378500 cites W2152240392 @default.
• W4324378500 cites W2155011514 @default.
• W4324378500 cites W2166023752 @default.
• W4324378500 cites W2271005668 @default.
• W4324378500 cites W2334838588 @default.
• W4324378500 cites W2340896985 @default.
• W4324378500 cites W2367561015 @default.
• W4324378500 cites W2761070087 @default.
• W4324378500 cites W2787617771 @default.
• W4324378500 cites W2792315641 @default.
• W4324378500 cites W2793173068 @default.
• W4324378500 cites W2795318993 @default.
• W4324378500 cites W2796937498 @default.
• W4324378500 cites W2888655787 @default.
• W4324378500 cites W2903131156 @default.
• W4324378500 cites W2913397411 @default.
• W4324378500 cites W2913894079 @default.
• W4324378500 cites W2916429144 @default.
• W4324378500 cites W2920860532 @default.
• W4324378500 cites W2921029492 @default.
• W4324378500 cites W2951949478 @default.
• W4324378500 cites W2955525647 @default.
• W4324378500 cites W2965573704 @default.
• W4324378500 cites W2977986462 @default.
• W4324378500 cites W2978389675 @default.
• W4324378500 cites W2979584256 @default.
• W4324378500 cites W2987515801 @default.
• W4324378500 cites W2992977610 @default.
• W4324378500 cites W2999214627 @default.
• W4324378500 cites W2999484073 @default.
• W4324378500 cites W3047500139 @default.
• W4324378500 cites W3049206514 @default.
• W4324378500 cites W3089025146 @default.
• W4324378500 cites W3092279411 @default.
• W4324378500 cites W3102720866 @default.
• W4324378500 cites W3112174823 @default.
• W4324378500 cites W3162422691 @default.
• W4324378500 cites W3173044264 @default.
• W4324378500 cites W3183404513 @default.
• W4324378500 cites W3188843792 @default.
• W4324378500 cites W3194940471 @default.
• W4324378500 cites W3195035598 @default.
• W4324378500 cites W3211008420 @default.
• W4324378500 cites W4205689341 @default.
• W4324378500 cites W4240273589 @default.
• W4324378500 cites W4243565408 @default.
• W4324378500 doi "https://doi.org/10.3389/fpsyt.2023.1083791" @default.
• W4324378500 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37009114" @default.
• W4324378500 hasPublicationYear "2023" @default.
• W4324378500 type Work @default.
• W4324378500 citedByCount "1" @default.
• W4324378500 countsByYear W43243785002023 @default.
• W4324378500 crossrefType "journal-article" @default.
• W4324378500 hasAuthorship W4324378500A5007719765 @default.
• W4324378500 hasAuthorship W4324378500A5008815054 @default.
• W4324378500 hasAuthorship W4324378500A5011645136 @default.
• W4324378500 hasAuthorship W4324378500A5032101247 @default.
• W4324378500 hasAuthorship W4324378500A5039633744 @default.
• W4324378500 hasAuthorship W4324378500A5039651095 @default.
• W4324378500 hasAuthorship W4324378500A5059810022 @default.
• W4324378500 hasAuthorship W4324378500A5067852989 @default.
• W4324378500 hasAuthorship W4324378500A5072748186 @default.
• W4324378500 hasAuthorship W4324378500A5084985802 @default.
• W4324378500 hasBestOaLocation W43243785001 @default.
• W4324378500 hasConcept C118552586 @default.
• W4324378500 hasConcept C126322002 @default.
• W4324378500 hasConcept C142724271 @default.
• W4324378500 hasConcept C168563851 @default.
• W4324378500 hasConcept C197934379 @default.
• W4324378500 hasConcept C204787440 @default.
• W4324378500 hasConcept C27081682 @default.

• next